Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704323 | SCV000527972 | benign | not provided | 2018-07-24 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001803739 | SCV002048850 | likely benign | Cardiomyopathy, familial hypertrophic 27 | 2023-11-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001704323 | SCV002492480 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002418298 | SCV002724832 | benign | Cardiovascular phenotype | 2019-02-21 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000438158 | SCV003928509 | likely benign | not specified | 2023-04-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004533060 | SCV004749691 | benign | ALPK3-related disorder | 2019-02-28 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000438158 | SCV001922248 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000438158 | SCV001968143 | benign | not specified | no assertion criteria provided | clinical testing |